Howard Hughes Medical Institute’s Calpine Corporation CPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-67,437
Closed -$912K 152
2017
Q2
$912K Sell
67,437
-13,164
-16% -$158K 0.17% 75
2017
Q1
$891K Sell
80,601
-31,714
-28% -$364K 0.16% 76
2016
Q4
$1.28M Buy
112,315
+50,268
+81% +$593K 0.29% 64
2016
Q3
$784K Buy
62,047
+46,205
+292% +$623K 0.2% 76
2016
Q2
$234K Buy
15,842
+8,921
+129% +$132K 0.08% 109
2016
Q1
$105K Buy
+6,921
New +$97.1K 0.02% 133
2014
Q4
Sell
-19,081
Closed -$414K 206
2014
Q3
$414K Buy
+19,081
New +$432K 0.09% 89

Other funds holding CPN

Howard Hughes Medical Institute's CPN Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Calpine Corporation (CPN) in Q3 2017, closing a stake of 67,437 shares — an estimated $912K sold.

Howard Hughes Medical Institute first reported a position in CPN in Q3 2014 and held it in 7 quarters. The position peaked at $1.28M in Q4 2016. 273 funds tracked by Wall St. Rank hold CPN as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Calpine Corporation position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 67,437 Calpine Corporation shares in Q3 2017, an estimated $912K.
  • Howard Hughes Medical Institute first reported a position in Calpine Corporation in Q3 2014 and held it in 7 quarters.
  • Howard Hughes Medical Institute's Calpine Corporation position peaked at $1.28M in Q4 2016.
  • 273 funds tracked by Wall St. Rank held Calpine Corporation as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.